Bristol-Myers Squibb Company
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2018
Total Assets: $34.99B
Liabilities Breakdown FY2018
Total Liabilities: $20.86B
Asset Breakdown
Total Assets: $34.99B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $6.91B | 19.8% |
| Accounts Receivable | $4.64B | 13.3% |
| Inventory | $1.20B | 3.4% |
| Property, Plant & Equipment | $5.03B | 14.4% |
| Goodwill | $6.54B | 18.7% |
| Intangible Assets | $1.09B | 3.1% |
| Other Assets | $9.59B | 27.4% |
Liabilities Breakdown
Total Liabilities: $20.86B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.89B | 9.1% |
| Long-Term Debt | $5.65B | 27.1% |
| Other Liabilities | $13.32B | 63.9% |